Literature DB >> 6532376

Ro 15-1570, a new sulfur-containing retinoid devoid of bone toxicity in rats.

A Kistler, H Sterz, K Teelmann.   

Abstract

Repeated ingestion of high doses of retinoids cause the so-called hypervitaminosis A syndrome. In rats the main symptoms are weight loss, alopecia, erythema, desquamation of the skin, and alterations of the skeletal system, including bone fractures. In the present study, three retinoids (Ro 15-1570, arotinoid ethylsulfone, 6 mg/kg; retinoic acid, 100 mg/kg and etretinate, 50 mg/kg) were administered orally to rats for 1 and 2 weeks, respectively, to six male and six female rats/group. All the above changes were induced by all three retinoids, with the exception that the arotinoid ethylsulfone Ro 15-1570 did not cause bone alterations. The absence of toxic effects on the bones by Ro 15-1570 was confirmed by X-ray-film examinations, densitometry of the X-rayed femora and tibiae, examination of the thickness of the femoral and tibial compacta in histological slides plus the determination of the femoral ash weight and its main inorganic constituents (calcium, magnesium, sodium, and potassium). The present demonstration that the arotinoid ethylsulfone Ro 15-1570 was devoid of bone toxicity constitutes major progress in the pharmacologic development of retinoids with a better balance between therapeutic and adverse effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532376     DOI: 10.1007/bf00349083

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  [The effect of massive doses of vitamin A in animal experiments].

Authors:  A STUDER
Journal:  Schweiz Z Pathol Bakteriol       Date:  1950

2.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

3.  [Formal pathogenesis of systemic diseases of the skeleton of animals].

Authors:  K Dämmrich
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1970-03-15       Impact factor: 0.328

4.  Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology.

Authors:  W Bollag
Journal:  Lancet       Date:  1983-04-16       Impact factor: 79.321

5.  Inhibition of vitamin A action in rat bone cultures by inhibitors of RNA and protein synthesis.

Authors:  A Kistler
Journal:  Experientia       Date:  1978-09-15

6.  Inhibition and reversion of chondrogenesis by retinoic acid in rat limb bud cell cultures.

Authors:  Françoise Gallandre; Andreas Kistler; Brigitta Galli
Journal:  Wilehm Roux Arch Dev Biol       Date:  1980-02

7.  Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro.

Authors:  N Sidell
Journal:  J Natl Cancer Inst       Date:  1982-04       Impact factor: 13.506

8.  Retinoic acid-induced cartilage resorption: induction of specific changes in protein synthesis and inhibition by tunicamycin.

Authors:  A Kistler
Journal:  Differentiation       Date:  1982-05       Impact factor: 3.880

Review 9.  Retinoids and cancer.

Authors:  W Bollag
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Arotinoids. A new class of retinoids with activities in oncology and dermatology.

Authors:  W Bollag
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

View more
  3 in total

1.  Prolactin lowering activity of the retinoid Ro 14-9706 affecting lactation and pup survival.

Authors:  A Edelmann; B Galli; U Hennes; A Kistler; H Kuhn; F Mettler
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

2.  Comparative teratogenicity of three retinoids: the arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570.

Authors:  A Kistler; B Galli; W B Howard
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Effects of etretinate on the distribution of elements in rats.

Authors:  N Krari; Y Mauras; P Allain
Journal:  Biol Trace Elem Res       Date:  1989-10       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.